BERWYN, Pa., May 20, 2019 /PRNewswire/ -- RM LAW, P.C. announces an investigation on behalf of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) ("Allscripts" or the "Company") investors concerning the Company and its officers' possible violations of federal securities laws.

If you purchased shares of Allscripts and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here.

On May 3, 2019, the Company disclosed that ''Practice Fusion, acquired by Allscripts on February 13, 2018, received in March 2017 a request for documents and information from the U.S. Attorney's Office for the District of Vermont'' pursuant to a civil investigative demand, and that ''[i]n March 2019, Practice Fusion received a grand jury subpoena in connection with a related criminal investigation.'' Allscripts further detailed how ''[t]he document and information requests received by Practice Fusion relate to both the certification Practice Fusion obtained in connection with the U.S. Department of Health and Human Services' Electronic Health Record Incentive Program and Practice Fusion's compliance with the Anti-Kickback Statute and HIPAA as it relates to certain business practices engaged in by Practice Fusion.'' Finally, the Company reported that ''[t]he outcome of the government investigation of Practice Fusion or any future government investigations of our other businesses could have a material adverse effect on our business, financial condition and operating results.''

For more information regarding this, please contact RM LAW, P.C.  (Richard A. Maniskas, Esquire) toll-free at (844) 291-9299 or by email at [email protected] or click here.   For more information about class action cases in general or to learn more about RM LAW, P.C. please visit our website by clicking here.